New paper by our #Neuropsychiatry group, published in Cognitive & Behavioral Neurology! 🧠
It's about a person who suffers from the Cotard Delusion in the context of Neuropsychiatric Systemic Lupus Erythematosus. How can we explain & treat this problem?
https://t.co/mEdi5dndOT
We share with sorrow the news of the passing of Dr. Kenneth M. Heilman, founding President of SBCN and giant in the field of behavioral neurology.
Please watch for opportunities to contribute as we make plans to honor and remember Dr. Heilman over the coming year.
Kenneth M. Heilman, a founder of the field of behavioral neurology who has died at 86, is remembered for impacting generations of young neurologists worldwide and serving @UFMedicine for over 50 years.
Read more: https://t.co/1WU2hGXRwK
Deadline extended! Applications for our Practice Leadership and Diversity Leadership programs are now due May 24.
Don't miss out—submit yours today! https://t.co/2Lve6jFgdF
#AANleadership#NeuroTwitter
Don't forget! Applications for our Practice Leadership, Diversity Leadership, and Emerging Leaders programs are due tomorrow, May 15!
Apply now: https://t.co/709t3Z46bw
#AANleadership#NeuroTwitter
Submission deadline is coming up fast:
Submit by 26 May (Sunday)
Join us in London for 10-11 September!
Preliminary Program is now online
https://t.co/D1oaxEJVLa
The Neurology Resident & Fellow Section (RFS) seeks neurology residents to serve a 3-year term as RFS Editorial Board members. Residents from accredited neurology training programs worldwide are invited to apply by July 15, 2024. Details: https://t.co/G8x2sqpbgL
#NeurologyRF
Around 8 million people globally are affected by #ParkinsonsDisease and around 10% of patients have a genetic predisposition
Join our upcoming webinar exploring advances in Parkinson’s disease genetics research, clinical practice, and diagnostic criteria: https://t.co/x2fJCHlm8R
After the @SBCNeuro reception in Boston in 2023, a number of the authors here had dinner. A topic of conversation was how to we bring new people into the fold of a subspecialty that we all love. This paper is the end result of that dinner. 🧵 1/n
https://t.co/xlDj8fsJau
When prion disease Isn’t suspected: prion disease as the cause of terminal decline in chronic mixed dementia: Neurocase. @RenegadeSynapse https://t.co/KEi1aJE7wO
A systems biology-based identification and in vivo functional screening of Alzheimer’s disease risk genes reveal modulators of memory function https://t.co/KM2wRUosTp
Allow me to share this new case study on #delusions of love & pasion in the behavioral variant of frontotemporal #dementia
🧵🧠💔
1/7
At age 59, after the death of her husband & after the loss of her son to suicide, Mrs M showed features of the so-called Clerambault delusion...
Longstanding Society for Behavioral and Cognitive Neurology member Dr. #DanPress speaking now on: Update on Preventing and Treating Cognitive Symptoms in Parkinson's.
LAST CHANCE to register for our next “Ask the Experts” webinar taking place TOMORROW May 4th @ 10am. Dr. Dan Press will be giving an “Update on Preventing and Treating Cognitive Symptoms in #Parkinson's.” Register for free on Zoom here https://t.co/ttBgWyifN5 #PD@ParkinsonDotOrg
How would 45 expert clinicians from 12 countries approach seven clinical vignettes from memory clinics?
It turns out clinical positive characteristics alone allow a very clear discrimination between FCD and neurodegeneration. Our #delphistudy is now out: https://t.co/3n46PbBE5J
While only getting started....congratulations to Prof. Jeremy Schmahmann for his receipt of the Society for Behavioral & Cognitive Neurology (@SBCNeuro) Lifetime Achievement Award. Transformative work at the intersection of the cerebellum & cognition. @SchmahmannLab@MGHNeurology
Wonderful evening of networking, fellowship & rich intellectual exchange at the Society for Behavioral and Cognitive Neurology reception this evening in Denver Colorado. #AANAM@SBCNeuro#BehavioralNeurology#Neuropsychiatry